177 related articles for article (PubMed ID: 25017632)
1. Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion.
Hale SL; Kloner RA
J Thromb Thrombolysis; 2015 Jan; 39(1):50-4. PubMed ID: 25017632
[TBL] [Abstract][Full Text] [Related]
2. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
Hale SL; Mehra A; Leeka J; Kloner RA
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H421-5. PubMed ID: 17993599
[TBL] [Abstract][Full Text] [Related]
3. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
Dai W; Hale S; Kloner RA
Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
[TBL] [Abstract][Full Text] [Related]
4. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
[TBL] [Abstract][Full Text] [Related]
5. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
[TBL] [Abstract][Full Text] [Related]
6. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
[TBL] [Abstract][Full Text] [Related]
7. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model.
Dai W; Amoedo ND; Perry J; Le Grand B; Boucard A; Carreno J; Zhao L; Brown DA; Rossignol R; Kloner RA
Cardiovasc Drugs Ther; 2022 Apr; 36(2):217-227. PubMed ID: 33555510
[TBL] [Abstract][Full Text] [Related]
8. Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction.
Hale SL; Dae MW; Kloner RA
Cardiovasc Res; 2003 Sep; 59(3):715-22. PubMed ID: 14499873
[TBL] [Abstract][Full Text] [Related]
9. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size.
Hale SL; Herring MJ; Kloner RA
J Am Heart Assoc; 2013 Jan; 2(1):e004234. PubMed ID: 23525431
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
[TBL] [Abstract][Full Text] [Related]
11. No-reflow phenomenon: maintaining vascular integrity.
Kloner RA
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):244-50. PubMed ID: 21821523
[TBL] [Abstract][Full Text] [Related]
12. The effect of CY1503, a sialyl Lewisx analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion.
Birnbaum Y; Patterson M; Kloner RA
J Mol Cell Cardiol; 1997 Aug; 29(8):2013-25. PubMed ID: 9281435
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):60-7. PubMed ID: 20133497
[TBL] [Abstract][Full Text] [Related]
14. Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: how fast and accurate can myocardial infarct size and no-reflow be predicted?
Uitterdijk A; Sneep S; van Duin RW; Krabbendam-Peters I; Gorsse-Bakker C; Duncker DJ; van der Giessen WJ; van Beusekom HM
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1104-10. PubMed ID: 23873799
[TBL] [Abstract][Full Text] [Related]
15. Continuous heliox breathing and the extent of anatomic zone of noreflow and necrosis following ischemia/reperfusion in the rabbit heart.
Hale SL; Vanderipe DR; Kloner RA
Open Cardiovasc Med J; 2013; 8():1-5. PubMed ID: 24587834
[TBL] [Abstract][Full Text] [Related]
16. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.
Reffelmann T; Hale SL; Li G; Kloner RA
Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H766-72. PubMed ID: 11788428
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
Jaffe R; Dick A; Strauss BH
JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
[TBL] [Abstract][Full Text] [Related]
18. Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model.
Stavrakis S; Terrovitis J; Tsolakis E; Drakos S; Dalianis A; Bonios M; Koudoumas D; Malliaras K; Nanas J
J Cardiovasc Transl Res; 2011 Feb; 4(1):99-105. PubMed ID: 21153063
[TBL] [Abstract][Full Text] [Related]
19. PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow.
Li XD; Cheng YT; Yang YJ; Meng XM; Zhao JL; Zhang HT; Wu YJ; You SJ; Wu YL
Microvasc Res; 2012 Jul; 84(1):44-54. PubMed ID: 22542438
[TBL] [Abstract][Full Text] [Related]
20. Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.
Zhao XJ; Liu XL; He GX; Xu HP
Braz J Med Biol Res; 2014 Feb; 47(3):245-51. PubMed ID: 24554037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
